Increased TGF-βRII expression correlates with PKM2 and HIF-1α, so it is possible that TGF-βRII might regulate glycolysis in oral CAFs, leading to affect the tumor progression in OSCC. The gene discussed is HIF1A; the disease is neoplasm.